The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017

Aging (Albany NY). 2021 Jan 12;13(1):279-300. doi: 10.18632/aging.104127. Epub 2021 Jan 12.

Abstract

Background: To evaluate the pattern and prevalence trends of liver cirrhosis caused by specific etiologies.

Results: Globally, the number of prevalent cases increased 74.53% from 1990 to 2017. The ASR increased 0.75 per year. The most pronounced increases were found in middle-high and high socio-demographic index (SDI) regions, especially in the Caribbean and Latin America. Among the etiologies, non-alcoholic steatohepatitis (NASH) related liver cirrhosis accounted for 59.46% of the cases. The ASR increased 1.74 per year, and the increase was observed in all 5 SDI regions. In addition, the ASR of liver cirrhosis caused by alcohol also increased in both sexes and all SDI regions. In contrast, the ASR of liver cirrhosis caused by hepatitis B virus (HBV) and hepatitis C virus (HCV) decreased, especially in middle and low-middle SDI regions.

Conclusions: Though the number of people suffering from HBV and HCV decreases, liver cirrhosis is still a major threat to health. Additionally, the number of people with cirrhosis caused by alcohol and NASH continues to grow. Thus, more targeted and specific strategies should be established based on etiology and prevalence trends of liver cirrhosis.

Methods: We collected data based on Global Burden of Disease (GBD) 2017 study. The age standardized prevalence rate (ASR) and estimated annual percentage changes (EAPC) were used to estimate the trends in prevalence by population, etiologies and regions.

Keywords: etiology; global burden of disease study; liver cirrhosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Global Burden of Disease / trends*
  • Hepatitis B / complications
  • Hepatitis C / complications
  • Humans
  • Liver Cirrhosis / epidemiology*
  • Liver Cirrhosis / etiology*
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / complications
  • Prevalence